# Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

> **NCT00854113** · PHASE1 · COMPLETED · sponsor: **Theracos** · enrollment: 78 (actual)

## Conditions studied

- Safety and Tolerability of EGT0001474 in Healthy Volunteers

## Interventions

- **DRUG:** EGT0001474
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00854113
- **Lead sponsor:** Theracos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2019-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00854113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00854113, "Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00854113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*